Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsy

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885 · see citing works

Requirement of Vascular Integrin α _v β ₃ for Angiogenesis

Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020 · see citing works

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · see citing works

Stages in the development of Parkinson’s disease-related pathology

Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689 · see citing works

Molecular regulation of vessel maturation

Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,515 · see citing works

Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262 · see citing works

Mixed brain pathologies account for most dementia cases in community-dwelling older persons

Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992 · see citing works

Progressive Supranuclear Palsy

Steele, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,930 · see citing works

Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen

Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683 · see citing works

Vascular endothelial growth factor (VEGF) stimulates neurogenesis <i>in vitro</i> and <i>in vivo</i>

Jin, K., Zhu, Y., Sun, Y., Mao, X. O., Xie, L., & Greenberg, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182296499 · Cited by 1,507 · see citing works

Neuropathology of older persons without cognitive impairment from two community-based studies

Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336 · see citing works

Definition of Two Angiogenic Pathways by Distinct α v Integrins

Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., & Cheresh, D. A. (1995) · Science · doi:10.1126/science.270.5241.1500 · Cited by 1,310 · see citing works

Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · see citing works

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease

Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172 · see citing works

The neuropathology of probable Alzheimer disease and mild cognitive impairment

Schneider, J. A., Arvanitakis, Z., Leurgans, S. E., & Bennett, D. A. (2009) · Annals of Neurology · doi:10.1002/ana.21706 · Cited by 935 · see citing works

Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)

Hauw, J., Daniel, S. E., Dickson, D. W., Horoupian, D. S., Jellinger, K. A., Lantos, P. L., McKee, A. C., Tabaton, M., & Litvan, I. (1994) · Neurology · doi:10.1212/wnl.44.11.2015 · Cited by 854 · see citing works

Glial reactions in Parkinson's disease

McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701 · see citing works

Vascular permeability, vascular hyperpermeability and angiogenesis

Nagy, J. A., Benjamin, L. E., Zeng, H., Dvořàk, A. M., & Dvorak, H. F. (2008) · Angiogenesis · doi:10.1007/s10456-008-9099-z · Cited by 629 · see citing works

Inflammation as a causative factor in the aetiology of Parkinson's disease

Whitton, P. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707167 · Cited by 625 · see citing works

Accuracy of Clinical Diagnosis in Parkinsonism — A Prospective Study

Rajput, A. H., Rozdilsky, B., & Rajput, A. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100031814 · Cited by 594 · see citing works

Three‐dimensional counting: An accurate and direct method to estimate numbers of cells in sectioned material

Williams, R. W., & RAKIC, P. T. (1988) · The Journal of Comparative Neurology · doi:10.1002/cne.902780305 · Cited by 426 · see citing works

Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition

Croisier, E., Moran, L. B., Dexter, D. T., Pearce, R. K., & Graeber, M. B. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-14 · Cited by 414 · see citing works

Decision Rules Guiding the Clinical Diagnosis of Alzheimer’s Disease in Two Community-Based Cohort Studies Compared to Standard Practice in a Clinic-Based Cohort Study

Bennett, D. A., Schneider, J. A., Aggarwal, N. T., Arvanitakis, Z., Shah, R. C., Kelly, J. F., Fox, J. H., Cochran, E. J., Arends, D., Treinkman, A., et al. (2006) · Neuroepidemiology · doi:10.1159/000096129 · Cited by 407 · see citing works

Microglial senescence: does the brain's immune system have an expiration date?

Streit, W. J. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.07.001 · Cited by 397 · see citing works

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

Lang, U., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 396 · see citing works

Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease

Reynolds, A. D., Stone, D. K., Hutter, J. A. L., Benner, E., Mosley, R., & Gendelman, H. E. (2010) · Journal of Immunology · doi:10.4049/jimmunol.0901852 · Cited by 391 · see citing works

The Inflammatory Reaction Following 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Intoxication in Mouse

Kurkowska‐Jastrzębska, I., Wrońska, A., Kohutnicka, M., Członkowski, A., & Członkowska, A. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6993 · Cited by 379 · see citing works

The Neuropathology of Older Persons with and Without Dementia from Community versus Clinic Cohorts

Schneider, J. A., Aggarwal, N. T., Barnes, L., Boyle, P., & Bennett, D. A. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1227 · Cited by 372 · see citing works

Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease

Dickson, D. W., Fujishiro, H., DelleDonne, A., Menke, J., Ahmed, Z., Klos, K. J., Josephs, K. A., Frigerio, R., Burnett, M., Parisi, J. E., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0345-7 · Cited by 364 · see citing works

Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons

Benner, E. J., Banerjee, R., Reynolds, A. D., Sherman, S., Писарев, В. М., Tsiperson, V., Nemachek, C., Ciborowski, P. S., Przedborski, S., Mosley, R. L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001376 · Cited by 359 · see citing works

Endogenous angiogenesis inhibitors

Folkman, J. (2004) · Apmis · doi:10.1111/j.1600-0463.2004.apm11207-0809.x · Cited by 321 · see citing works

Collateral Growth and Angiogenesis Around Cortical Stroke

Wei, L., Erinjeri, J. P., Rovainen, C. M., & Woolsey, T. A. (2001) · Stroke · doi:10.1161/hs0901.094282 · Cited by 301 · see citing works

Neuroanatomy and Pathology of Sporadic Parkinson's Disease

Braak, H., & Tredici, K. D. (2008) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-540-79850-7 · Cited by 297 · see citing works

Role of Inflammatory Mediators in Angiogenesis

Naldini, A., & Carraro, F. (2005) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010053622830 · Cited by 287 · see citing works

Alzheimer's disease and angiogenesis

Vagnucci, A. H., & Li, W. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12521-4 · Cited by 267 · see citing works

Regulation of gene expression by hypoxia

Kenneth, N. S., & Rocha, S. (2008) · Biochemical Journal · doi:10.1042/bj20081055 · Cited by 264 · see citing works

Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys

Judith Miklossy, A., Doudet, D., Schwab, C., Yu, S. Y., McGeer, E. G., & McGeer, P. L. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.034 · Cited by 255 · see citing works

The Blood Brain Barrier in Neurodegenerative Disease: A Rhetorical Perspective

Carvey, P., Hendey, B., & Monahan, A. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06319.x · Cited by 254 · see citing works

Integrin Subunit Gene Expression Is Regionally Differentiated in Adult Brain

Pinkstaff, J. K., Detterich, J., Lynch, G., & Gall, C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-05-01541.1999 · Cited by 250 · see citing works

Neurodegenerative basis of age-related cognitive decline

Wilson, R. S., Leurgans, S. E., Boyle, P. A., Schneider, J. A., & Bennett, D. A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f39adc · Cited by 234 · see citing works

Antiangiogenic therapy for cancer: current and emerging concepts.

Coiffier, B., & Reyes, F. (2005) · PubMed · Cited by 231 · see citing works

Alzheimer's disease and angiogenesis

Agorogiannis, E. I., & Agorogiannis, G. I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13000-0 · Cited by 224 · see citing works

Markers for Microscopic Imaging of Lymphangiogenesis and Angiogenesis

Bałuk, P., & McDonald, D. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1413.001 · Cited by 222 · see citing works

Blood vessels change in the mesencephalon of patients with Parkinson's disease

Faucheux, B. A., Agid, Y., Hirsch, É. C., & Bonnet, A.-M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00641-8 · Cited by 218 · see citing works

6-Hydroxydopamine-induced alterations in blood-brain barrier permeability

Carvey, P. M., Zhao, C. H., Hendey, B., Lum, H., Trachtenberg, J., Desai, B. S., Snyder, J., Zhu, Y. G., & Ling, Z. D. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04281.x · Cited by 218 · see citing works

Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease

Yasuhara, T., Shingo, T., Kobayashi, K., Takeuchi, A., Yano, A., Muraoka, K., Matsui, T., Miyoshi, Y., Hamada, H., & Date, I. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03254.x · Cited by 216 · see citing works

Microglial Activation parallels System Degeneration in progressive Supranuclear palsy and Corticobasal Degeneration

Ishizawa, K., & Dickson, D. W. (2001) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1093/jnen/60.6.647 · Cited by 209 · see citing works

Dual-targeted Contrast Agent for US Assessment of Tumor Angiogenesis in Vivo

Willmann, J. K., Lutz, A. M., Paulmurugan, R., Patel, M. R., Chu, P., Rosenberg, J., & Gambhir, S. S. (2008) · Radiology · doi:10.1148/radiol.2483072231 · Cited by 206 · see citing works

Incidental Lewy Body Disease and Preclinical Parkinson Disease

DelleDonne, A., Klos, K. J., Fujishiro, H., Ahmed, Z., Parisi, J. E., Josephs, K. A., Frigerio, R., Burnett, M. S., Wszołek, Z. K., Uitti, R. J., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.8.1074 · Cited by 197 · see citing works

Role of integrins in angiogenesis

Brooks, P. C. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00381-4 · Cited by 194 · see citing works

Caffeine protects against MPTP‐induced blood‐brain barrier dysfunction in mouse striatum

Chen, X., Lan, X., Roche, I., Liu, R., & Geiger, J. D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05697.x · Cited by 189 · see citing works

VEGF-mediated inflammation precedes angiogenesis in adult brain

Croll, S. D. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.02.010 · Cited by 184 · see citing works

The Extracellular Matrix and Cytokines Regulate Microglial Integrin Expression and Activation

Milner, R., & Campbell, I. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3850 · Cited by 179 · see citing works

In vivo imaging of microglial activation with [¹¹C](R)‐PK11195 PET in progressive supranuclear palsy

Gerhard, A., Trender‐Gerhard, I., Turkheimer, F., Quinn, N. P., Bhatia, K. P., & Brooks, D. J. (2006) · Movement Disorders · doi:10.1002/mds.20668 · Cited by 171 · see citing works

Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank

Josephs, K. A., & Dickson, D. W. (2003) · Movement Disorders · doi:10.1002/mds.10488 · Cited by 163 · see citing works

Evidence of angiogenic vessels in Alzheimer’s disease

Desai, B. S., Schneider, J. A., Li, J.-L., Carvey, P. M., & Hendey, B. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0226-9 · Cited by 153 · see citing works

Role of striatal l ‐DOPA in the production of dyskinesia in 6‐hydroxydopamine lesioned rats

Carta, M., Lindgren, H. S., Lundblad, M., Stancampiano, R., Fadda, F., & Cenci, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03696.x · Cited by 150 · see citing works

The role of neuroinflammation on the pathogenesis of Parkinson's disease

Chung, Y. C., Ko, H. W., Bok, E., Park, E. S., Huh, S. H., Nam, J. H., & Jin, B. K. (2010) · BMB Reports · doi:10.5483/bmbrep.2010.43.4.225 · Cited by 148 · see citing works

Blood–brain barrier disruption induces <i>in vivo</i> degeneration of nigral dopaminergic neurons

Rite, I., Machado, A., Cano, J., & Venero, J. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04567.x · Cited by 147 · see citing works

Endothelial Proliferation and Increased Blood–Brain Barrier Permeability in the Basal Ganglia in a Rat Model of 3,4-Dihydroxyphenyl-l-Alanine-Induced Dyskinesia

Westin, J. E., Lindgren, H. S., Gardi, J. E., Nyengaard, J. R., Brundin, P., Mohapel, P., & Cenci, M. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0944-06.2006 · Cited by 130 · see citing works

Regulated Angiogenesis and Vascular Regression in Mice Overexpressing Vascular Endothelial Growth Factor in Airways

Bałuk, P., Lee, C. G., Link, H., Ator, E., Haskell, A., Elias, J. A., & McDonald, D. M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63369-x · Cited by 124 · see citing works

Immunohistochemical localization of vitronectin, its receptor and beta-3 integrin in Alzheimer brain tissue

Akiyama, H., Kawamata, T., Dedhar, S., & McGeer, P. L. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90067-h · Cited by 120 · see citing works

Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian

Barcia, C., Bautista‐Hernández, V., Sánchez-Bahíllo, A., Fernández‐Villalba, E., Faucheux, B. A., Poza, M., Barreiro, A. F., Hirsch, É. C., & Herrero, M. T. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0256-2 · Cited by 119 · see citing works

Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease

Thirumangalakudi, L., Samany, P. G., Owoso, A., Wiskar, B., & Grammas, P. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10114 · Cited by 117 · see citing works

Expression levels of vascular endothelial growth factor and its receptors in Parkinson's disease

Wada, K., Arai, H., Takanashi, M., Fukae, J., Oizumi, H., Yasuda, T., Mizuno, Y., & Mochizuki, H. (2006) · NeuroReport · doi:10.1097/01.wnr.0000215769.71657.65 · Cited by 109 · see citing works

Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease.

Bertrand, E., Lechowicz, W., Szpak, G. M., & Dymecki, J. (1997) · PubMed · Cited by 95 · see citing works

VEGF and angiogenesis in acute and chronic MOG(35–55) peptide induced EAE

Roscoe, W. A., Welsh, M. E., Carter, D. E., & Karlik, S. J. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.01.009 · Cited by 94 · see citing works

Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter

Holley, J. E., Newcombe, J., Whatmore, J. L., & Gutowski, N. J. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.12.059 · Cited by 91 · see citing works

Differential Involvement of D1 and D2 Dopamine Receptors in L-DOPA-Induced Angiogenic Activity in a Rat Model of Parkinson's Disease

Lindgren, H. S., Ohlin, K. E., & Cenci, M. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.74 · Cited by 84 · see citing works

The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model

Yasuhara, T., Shingo, T., Muraoka, K., Ji, Y., Kameda, M., Takeuchi, A., Yano, A., Nishio, S., Matsui, T., Miyoshi, Y., et al. (2005) · Brain Research · doi:10.1016/j.brainres.2004.12.055 · Cited by 77 · see citing works

Ongoing angiogenesis in blood vessels of the abdominal aortic aneurysm

Paik, D. C., Fu, C., Bhattacharya, J., & Tilson, M. D. (2004) · Experimental & Molecular Medicine · doi:10.1038/emm.2004.67 · Cited by 75 · see citing works

Astrocyte responses to injury: VEGF simultaneously modulates cell death and proliferation

Schmid-Brunclik, N., Taboada, C. B., Antoniou, X., Gassmann, M., & Ogunshola, O. O. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00536.2007 · Cited by 71 · see citing works

Angiogenesis in multiple sclerosis: is it good, bad or an epiphenomenon?

Kirk, S., Frank, J. A., & Karlik, S. J. (2003) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.10.016 · Cited by 71 · see citing works

Controversies over the staging of α-synuclein pathology in Parkinson’s disease

Kalaitzakis, M. E., Graeber, M. B., Gentleman, S. M., & Pearce, R. K. B. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0381-3 · Cited by 68 · see citing works

Angiogenic signaling in Alzheimer's disease

Pogue, A. I., & Lukiw, W. J. (2004) · Neuroreport · doi:10.1097/01.wnr.0000130539.39937.1d · Cited by 65 · see citing works

Age and region‐specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine exposure in monkeys

Kanaan, N. M., Kordower, J. H., & Collier, T. J. (2008) · Glia · doi:10.1002/glia.20690 · Cited by 64 · see citing works

Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease

Yasuda, T., Tani, M., Nihira, T., Wada, K., Hattori, N., Mizuno, Y., & Mochizuki, H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.012 · Cited by 60 · see citing works

Vitronectin receptor: tissue specific expression or adaptation to culture?

Horton, M. A. (1990) · PubMed · Cited by 58 · see citing works

Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat

Jonkers, N., Sarre, S., Ebinger, G., & Michotte, Y. M. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170056 · Cited by 57 · see citing works

Activated astrocytes induce nitric oxide synthase-2 in cerebral endothelium via tumor necrosis factor ?

Shafer, R. A., & Murphy, S. P. (1997) · Glia · doi:10.1002/(sici)1098-1136(199712)21:4 · Cited by 51 · see citing works

Effects of Benserazide on L-DOPA-Derived Extracellular Dopamine Levels and Aromatic L-Amino Acid Decarboxylase Activity in the Striatum of 6-Hydroxydopamine-Lesioned Rats

Shen, H., Kannari, K., Yamato, H., Arai, A., & Matsunaga, M. (2003) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.199.149 · Cited by 48 · see citing works

Targeted imaging of hypoxia-induced integrin activation in myocardium early after infarction

Kalinowski, L., Dobrucki, L. W., Meoli, D. F., Dione, D. P., Sadeghi, M. M., Madri, J. A., & Sinusas, A. J. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00861.2007 · Cited by 43 · see citing works

Blood vessels and Parkinsonism

Barcia, C. (2004) · Frontiers in Bioscience · doi:10.2741/1145 · Cited by 41 · see citing works

In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer’s disease

Schultheiß, C., Blechert, B., Gaertner, F. C., Drecoll, E., Mueller, J., Weber, G. F., Drzezga, A. E., & Essler, M. (2006) · Angiogenesis · doi:10.1007/s10456-006-9030-4 · Cited by 35 · see citing works

The blood–brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates—Evidence from in vivo neuroimaging studies

Astradsson, A., Jenkins, B. G., Choi, J., Hallett, P. J., Levesque, M. A., McDowell, J. S., Brownell, A., Spealman, R. D., & Ole Isacson, A. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.018 · Cited by 34 · see citing works

Treatment of hypoxia‐induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of disease

Lahdenranta, J., Sidman, R. L., Pasqualini, R., & Arap, W. (2007) · The FASEB Journal · doi:10.1096/fj.07-8273com · Cited by 27 · see citing works

Progressive supranuclear palsy (PSP): a quantitative study of the pathological changes in cortical and subcortical regions of eight cases

Armstrong, R. A., Lantos, P. L., & Cairns, N. J. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0796-3 · Cited by 23 · see citing works

Pathophysiologie des sporadischen Morbus Parkinson*

Braak, H., & Tredici, K. D. (2010) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0029-1245179 · Cited by 19 · see citing works

L-dopa-carbidopa: combined therapy for the treatment of Parkinson's disease.

Celesia, G. G., & Wanamaker, W. M. (1976) · PubMed · Cited by 12 · see citing works

Reply to “Controversies over the staging of α-synuclein pathology in Parkinson’s disease”

Braak, H., & Tredici, K. D. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0399-6 · Cited by 6 · see citing works

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076 · see citing works

Blood-Brain Barrier: From Physiology to Disease and Back

Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616 · see citing works

Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases

Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609 · see citing works

The blood–brain barrier in health and disease

Daneman, R. (2012) · Annals of Neurology · doi:10.1002/ana.23648 · Cited by 756 · see citing works

Nanomaterial-based blood-brain-barrier (BBB) crossing strategies

Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119491 · Cited by 604 · see citing works

Astrocytic modulation of blood brain barrier: perspectives on Parkinson’s disease

Cabezas, R., Ávila, M. F., González, J., El-Bachá, R. D. S., Báez-Jurado, E., García‐Segura, L. M., Jurado-Coronel, J. C., Capani, F., Cardona‐Gómez, G. P., & Barreto, G. E. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00211 · Cited by 453 · see citing works

Targeting the transferrin receptor for brain drug delivery

Johnsen, K. B., Burkhart, A., Thomsen, L. B., Andresen, T. L., & Moos, T. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101665 · Cited by 371 · see citing works

Microglia–blood vessel interactions: a double-edged sword in brain pathologies

Dudvarski Stankovic, N., Teodorczyk, M., Ploen, R., Zipp, F., & Schmidt, M. H. H. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1524-y · Cited by 301 · see citing works

Neurovascular Unit Dysfunction and Neurodegenerative Disorders

Yu, X., Ji, C., & Shao, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00334 · Cited by 244 · see citing works

Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications

Cenci, M. A. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00242 · Cited by 239 · see citing works

Inflammation in Parkinson's Disease

Tüfekçi, K. U., Meuwissen, R. L. J., Genç, Ş., & Genç, K. (2012) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-398314-5.00004-0 · Cited by 199 · see citing works

Vascular Degeneration in <scp>P</scp>arkinson's Disease

Guan, J., Pavlovic, D., Dalkie, N., Waldvogel, H. J., O'Carroll, S. J., Green, C. R., & Nicholson, L. F. B. (2013) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00628.x · Cited by 191 · see citing works

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities

Araújo, B., Caridade-Silva, R., Soares-Guedes, C., Martins‐Macedo, J., Gomes, E. D., Monteiro, S., & Teixeira, F. G. (2022) · Cells · doi:10.3390/cells11182908 · Cited by 198 · see citing works

Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells

Garretti, F., Agalliu, D., Arlehamn, C. S. L., Sette, A., & Sulzer, D. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00303 · Cited by 162 · see citing works

Blood–brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy

Lau, K., Kotzur, R., & Richter, F. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00430-z · Cited by 165 · see citing works

Increased CSF biomarkers of angiogenesis in Parkinson disease

Janelidze, S., Lindqvist, D., Francardo, V., Hall, S., Zetterberg, H., Blennow, K., Adler, C. H., Beach, T. G., Serrano, G. E., van Westen, D., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002151 · Cited by 150 · see citing works

Blood-CNS Barrier Impairment in ALS patients versus an animal model

Garbuzova-Davis, S. N., & Sanberg, P. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00021 · Cited by 146 · see citing works

Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease

Lee, J., Martín‐Bastida, A., Murueta‐Goyena, A., Gabilondo, I., Cuenca, N., Piccini, P. P., & Jeon, B. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00618-9 · Cited by 131 · see citing works

The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease

Baizabal-Carvallo, J. F., & Alonso-Juarez, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.030 · Cited by 130 · see citing works

Human α-synuclein overexpression in a mouse model of Parkinson’s disease leads to vascular pathology, blood brain barrier leakage and pericyte activation

Elabi, O. F., Gaceb, A., Carlsson, R., Padel, T., Soylu-Kucharz, R., Cortijo, I., Li, W., Li, J., & Paul, G. (2021) · Scientific Reports · doi:10.1038/s41598-020-80889-8 · Cited by 127 · see citing works

Neuropathology of incidental Lewy body & prodromal Parkinson’s disease

Koeglsperger, T., Rumpf, S.-L., Schließer, P., Struebing, F. L., Brendel, M., Levin, J., Trenkwalder, C., Höglinger, G. U., & Herms, J. W. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00622-7 · Cited by 133 · see citing works

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis

Girolamo, F., Coppola, C., Ribatti, D., & Trojano, M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0084-z · Cited by 124 · see citing works

The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson’s disease

Jacquet, A. D. R., Alpaugh, M., Denis, H. L., Tancredi, J. L., Boutin, M., Decaestecker, J., Beauparlant, C., Herrmann, L., Saint-Pierre, M., Parent, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39038-8 · Cited by 114 · see citing works

Microglial interactions with the neurovascular system in physiology and pathology

Zhao, X., Eyo, U. B., Murugan, M., & Wu, L. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22576 · Cited by 109 · see citing works

Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease

Bortolanza, M., Nascimento, G. C., Socías, S. B., Ploper, D., Chehín, R. N., Raisman‐Vozari, R., & Bel, E. A. D. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1913-1 · Cited by 105 · see citing works

MSC-Derived Exosomes can Enhance the Angiogenesis of Human Brain MECs and Show Therapeutic Potential in a Mouse Model of Parkinson's Disease

Xue, C., Li, X., Ba, L., Zhang, M., Yang, Y., Gao, Y., Sun, Z., Han, Q., & Zhao, R. C. (2021) · Aging and disease · doi:10.14336/ad.2020.1221 · Cited by 100 · see citing works

Disruption of the blood-brain barrier in parkinson's disease: curse or route to a cure?

Lee, H. (2014) · Frontiers in bioscience · doi:10.2741/4206 · Cited by 96 · see citing works

Microvascular Changes in Parkinson’s Disease- Focus on the Neurovascular Unit

Paul, G., & Elabi, O. F. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.853372 · Cited by 97 · see citing works

Neuroinflammatory Responses and Parkinson’ Disease: Pathogenic Mechanisms and Therapeutic Targets

Yang, L., Mao, K., Yu, H., & Chen, J. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09926-7 · Cited by 90 · see citing works

Blood–brain barrier endothelial cells in neurodegenerative diseases: Signals from the “barrier”

Yuan, Y., Sun, J., Dong, Q., & Cui, M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1047778 · Cited by 86 · see citing works

Red/near-infrared irradiation therapy for treatment of central nervous system injuries and disorders

Fitzgerald, M., Hodgetts, S. I., van den Heuvel, C., Natoli, R., Hart, N. S., Valter, K., Harvey, A. R., Vink, R., Provis, J. M., & Dunlop, S. A. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2012-0086 · Cited by 82 · see citing works

Unveiling sex-based differences in Parkinson's disease: a comprehensive meta-analysis of transcriptomic studies

López‐Cerdán, A., Andreu, Z., Hidalgo, M. R., Grillo-Risco, R., Català-Senent, J. F., Soler-Sáez, I., Neva-Alejo, A., Gordillo, F., de la Iglesia-Vayá, M., & Garcia‐García, F. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00477-5 · Cited by 77 · see citing works

Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease

Ohlin, K. E., Sebastianutto, I., Adkins, C. E., Lundblad, C., Lockman, P. R., & Cenci, M. A. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.02.066 · Cited by 77 · see citing works

Small Vessels Are a Big Problem in Neurodegeneration and Neuroprotection

Erdener, Ş. E., & Dalkara, T. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00889 · Cited by 76 · see citing works

In vitro models and systems for evaluating the dynamics of drug delivery to the healthy and diseased brain

Modarres, H. P., Janmaleki, M., Novin, M., Saliba, J., Moussa, F. E. H., Charan, M. R., Seyfoori, A., SadAbadi, H., Vandal, M., Nguyen, M. D., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.01.024 · Cited by 73 · see citing works

Cerebrovascular plasticity: Processes that lead to changes in the architecture of brain microvessels

Bogorad, M. I., DeStefano, J. G., Linville, R. M., Wong, A. D., & Searson, P. C. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19855875 · Cited by 72 · see citing works

An altered blood–brain barrier contributes to brain iron accumulation and neuroinflammation in the 6-OHDA rat model of Parkinson’s disease

Olmedo‐Díaz, S., Estévez-Silva, H. M., Orädd, G., af Bjerkén, S., Marcellino, D. J., & Virel, A. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.08.023 · Cited by 71 · see citing works

Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson's disease

Padel, T., Özen, I., Boix, J., Barbariga, M., Gaceb, A., Roth, M., & Paul, G. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.06.002 · Cited by 70 · see citing works

Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β

Muñoz, A., Garrido‐Gil, P., Dominguez‐Meijide, A., & Labandeira-García, J. L. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.08.019 · Cited by 69 · see citing works

Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?

Armentero, M., Cerri, S., & Blandini, F. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00232 · Cited by 70 · see citing works

Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP)

Alster, P., Madetko‐Alster, N., Koziorowski, D., & Friedman, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00893 · Cited by 66 · see citing works

Iron Deposition in Parkinson’s Disease: A Mini-Review

Zeng, W., Cai, J., Zhang, L., & Peng, Q. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01459-4 · Cited by 64 · see citing works

Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives

Bogale, T. A., Faustini, G., Longhena, F., Mitola, S. M. F., Pizzi, M., & Bellucci, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.611761 · Cited by 59 · see citing works

Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease

Kaur, G., Behl, T., BUNGAU, S. G., Kumar, A., Uddin, M. S., Mehta, V., Zengin, G., Mathew, B., Shah, M. A., & Arora, S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200606233050 · Cited by 56 · see citing works

High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease

Elabi, O. F., da Cunha, J. P. M. C. M., Gaceb, A., Fex, M., & Paul, G. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02218-8 · Cited by 58 · see citing works

The Role of the Vascular System in Degenerative Diseases: Mechanisms and Implications

Sheikh, A. M., Yano, S., Tabassum, S., & Nagai, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042169 · Cited by 52 · see citing works

Brain barriers in health and disease

Daneman, R., & Engelhardt, B. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.05.008 · Cited by 51 · see citing works

Dysfunction of the neurovascular unit in diabetes-related neurodegeneration

Yan, C., Zhou, Y., Chen, Q., Luo, Y., Zhang, J. H., Huang, H., & Shao, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110656 · Cited by 44 · see citing works

The avascular zone and neuronal remodeling of the fovea in Parkinson disease

Miri, S., Shrier, E. M., Glazman, S., Ding, Y., Selesnick, I., Kozlowski, P. B., & Bodis-Wollner, I. G. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.146 · Cited by 42 · see citing works

Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid

Bastos, P. A. D., Ferreira, R. M., Manadas, B. J., Moreira, P. I., & Vitorino, R. M. P. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1299682 · Cited by 40 · see citing works

Molecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease

Долгачева, Л. П., Зинченко, В. П., & Goncharov, N. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113043 · Cited by 41 · see citing works

Subvoxel vascular imaging of the midbrain using USPIO-Enhanced MRI

Buch, S., Wang, Y., Park, M., Jella, P. K., Hu, J., Chen, Y., Shah, K., Ge, Y., & Haacke, E. M. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117106 · Cited by 38 · see citing works

Foveal Remodeling of Retinal Microvasculature in Parkinson’s Disease

Murueta‐Goyena, A., Barrenechea, M., Erramuzpe, A., Teijeira‐Portas, S., Pengo, M., Ayala, U., Romero-Bascones, D., Acera, M., Pino, R. D., Gómez‐Esteban, J. C., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.708700 · Cited by 37 · see citing works

Vascular, flow and perfusion abnormalities in Parkinson's disease

Zhang, C., Wu, B., Wang, X., Chen, C., Zhao, R.-C., Lu, H., Zhu, H., Xue, B., Liang, H., Sethi, S. K., et al. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.02.019 · Cited by 37 · see citing works

T cells, α-synuclein and Parkinson disease

Garretti, F., Monahan, C., Sette, A., Agalliu, D., & Sulzer, D. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00023-0 · Cited by 39 · see citing works

Photobiomodulation Mitigates Cerebrovascular Leakage Induced by the Parkinsonian Neurotoxin MPTP

Miguel, M. S., Martin, K. L., Stone, J., & Johnstone, D. M. (2019) · Biomolecules · doi:10.3390/biom9100564 · Cited by 37 · see citing works

Brain and retinal microglia in health and disease: An unrecognized target of the renin–angiotensin system

McCarthy, C. A., Widdop, R. E., Deliyanti, D., & Wilkinson‐Berka, J. L. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12099 · Cited by 36 · see citing works

Blood-brain Barrier and Neurovascular Unit Dysfunction in Parkinson's Disease: From Clinical Insights to Pathogenic Mechanisms and Novel Therapeutic Approaches

Khor, S. L. Q., Ng, K. Y., Koh, R. Y., & Chye, S. M. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230330093829 · Cited by 35 · see citing works

Is brain gliosis a characteristic of chronic methamphetamine use in the human?

Tong, J., Fitzmaurice, P. S., Furukawa, Y., Schmunk, G. A., Wickham, D. J., Ang, L.-C., Sherwin, A. L., McCluskey, T., Boileau, I., & Kish, S. J. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.03.015 · Cited by 34 · see citing works

Aberrantly expressed long noncoding RNAs and genes in Parkinson's disease

Zhou, Y., Cheng-zhi, G., Li, J., Zhu, L., Huang, G., Dai, J., & Huaiyu, H. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s178435 · Cited by 32 · see citing works

Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson’s Disease: A Perspective on Associated Therapeutic Interventions

Behl, T., Kaur, G., BUNGAU, S. G., Jhanji, R., Kumar, A., Mehta, V., Zengin, G., Brata, R. D., Hassan, S. S. U., & Frățilă, O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176235 · Cited by 34 · see citing works

Glycation: The angiogenic paradox in aging and age-related disorders and diseases

Roca, F., Grossin, N., Chassagne, P., Puisieux, F. L., & Boulanger, É. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.03.009 · Cited by 33 · see citing works

Neurovascular abnormalities in brain disorders: highlights with angiogenesis and magnetic resonance imaging studies

Chen, C.-C. V., Chen, Y., Hsiao, H., Chang, C., & Chern, Y. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-47 · Cited by 31 · see citing works

Challenges and Future Perspectives in Modeling Neurodegenerative Diseases Using Organ‐on‐a‐Chip Technology

Pramotton, F. M., Spitz, S., & Kamm, R. D. (2024) · Advanced Science · doi:10.1002/advs.202403892 · Cited by 33 · see citing works

Anti-inflammatory and Neuroprotective Effects of Transcranial Ultrasound Stimulation on Parkinson's Disease

Song, W.-S., Sung, C.-Y., Ke, C., & Yang, F. (2021) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2021.10.001 · Cited by 31 · see citing works

LncRNAs as putative biomarkers and therapeutic targets for Parkinson’s disease

Taghizadeh, E., Hayat, S. M. G., Taheri, F., Afshani, S. M. R., Farahani, N., & Saberi, A. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05408-7 · Cited by 30 · see citing works

Endothelial Senescence and Its Impact on Angiogenesis in Alzheimer’s Disease

Georgieva, I., Tchekalarova, J. D., Iliev, D. B., & Tzoneva, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411344 · Cited by 29 · see citing works

CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease

Fowler, A. J., Ahn, J., Hebron, M., Chiu, T., Ayoub, R., Mulki, S., Ressom, H., Torres-Yaghi, Y., Wilmarth, B., Pagan, F. L., et al. (2021) · Neurology Genetics · doi:10.1212/nxg.0000000000000633 · Cited by 29 · see citing works

Progressive Supranuclear Palsy Syndrome: An Overview

Ichikawa-Escamilla, E., Velasco-Martínez, R. A., & Adalid-Peralta, L. V. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.04.008 · Cited by 26 · see citing works

Reduction of microhemorrhages in the spinal cord of symptomatic ALS mice after intravenous human bone marrow stem cell transplantation accompanies repair of the blood-spinal cord barrier

Eve, D. J., Steiner, G. A., Mahendrasah, A., Sanberg, P. R., Kurien, C., Thomson, A., Borlongan, C. V., & Garbuzova-Davis, S. N. (2018) · Oncotarget · doi:10.18632/oncotarget.24360 · Cited by 26 · see citing works

The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease

Sim, K.-Y., Im, K. C., & Park, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155295 · Cited by 24 · see citing works

Microcirculation of the brain: morphological assessment in degenerative diseases and restoration processes

Kolinko, Y., Krakorová, K., Cendelín, J., Tonar, Z., & Králíčková, M. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0049 · Cited by 24 · see citing works

Mitigating neuroinflammation in Parkinson's disease: Exploring the role of proinflammatory cytokines and the potential of phytochemicals as natural therapeutics

Sharma, P. K., Kishore, A., De, I., Negi, S., Kumar, G., Bhardwaj, S., & Singh, M. P. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105604 · Cited by 24 · see citing works

The Cerebrovascular Side of Plasticity: Microvascular Architecture across Health and Neurodegenerative and Vascular Diseases

Zedde, M., & Pascarella, R. (2024) · Brain Sciences · doi:10.3390/brainsci14100983 · Cited by 21 · see citing works

Imaging Parkinsonian Pathology in Substantia Nigra with MRI

Huddleston, D. E., Langley, J. A., Dušek, P., He, N., Faraco, C. C., Crosson, B., Factor, S. A., & Hu, X. P. (2018) · Current Radiology Reports · doi:10.1007/s40134-018-0272-x · Cited by 21 · see citing works

A cortical microvascular structure in vascular dementia, Alzheimer's disease, frontotemporal lobar degeneration and nondemented controls: a sign of angiogenesis due to brain ischaemia?

Olofsson, H. E., & Englund, E. M. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12552 · Cited by 21 · see citing works

The role of reactive oxygen species in the regulation of the blood-brain barrier

Shuvalova, M. L., Dmitrieva, A., Belousov, V. V., & Nosov, G. (2024) · Tissue Barriers · doi:10.1080/21688370.2024.2361202 · Cited by 21 · see citing works

An integrated approach to unravel a putative crosstalk network in Alzheimer’s disease and Parkinson’s disease

Bisht, I., Ambasta, R. K., & Kumar, P. (2020) · Neuropeptides · doi:10.1016/j.npep.2020.102078 · Cited by 20 · see citing works

Increased putamen hypercapnic vasoreactivity in levodopa-induced dyskinesia

Jourdain, V. A., Schindlbeck, K. A., Tang, C. C., Niethammer, M., Choi, Y. Y., Markowitz, D. M., Nazem, A., Nardi, D., Carras, N. G., Feigin, A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.96411 · Cited by 20 · see citing works

Microglia‐Related Gene Triggering Receptor Expressed in Myeloid Cells 2 (<i>TREM2</i>) Is Upregulated in the Substantia Nigra of Progressive Supranuclear Palsy

Sánchez‐Ruiz de Gordoa, J., Erro, M. E., Vicuña‐Urriza, J., Zelaya, M. V., Tellechea, P., Acha, B., Zueco, S., Urdánoz‐Casado, A., Roldán, M., Blanco‐Luquin, I., et al. (2020) · Movement Disorders · doi:10.1002/mds.27992 · Cited by 18 · see citing works

Impaired cerebral microcirculation in isolated REM sleep behaviour disorder

Eskildsen, S. F., Iranzo, Á., Stokholm, M. G., Stær, K., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., et al. (2021) · Brain · doi:10.1093/brain/awab054 · Cited by 15 · see citing works

HTRA1 Regulates Subclinical Inflammation and Activates Proangiogenic Response in the Retina and Choroid

Shihabuddeen, W. A., Yu, R. M. C., Pan, Y., Iwata, T., Barathi, V. A., Wey, Y. S., Tun, S. B. B., Qiu, B., Tan, A., Wang, X., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810206 · Cited by 14 · see citing works

Carnosic acid protects starvation-induced SH-SY5Y cell death through Erk1/2 and Akt pathways, autophagy, and FoxO3a

Shibata, S., Ishitobi, H., Miyaki, S., Kawaoka, T., Kayashima, T., & Matsubara, K. (2016) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2016.1208734 · Cited by 14 · see citing works

Crosstalk between neuroinflammation and ferroptosis: Implications for Parkinson’s disease progression

Guo, X., Wei, R., Yin, X., & Yang, G. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1528538 · Cited by 13 · see citing works

The STRAT-PARK cohort: A personalized initiative to stratify Parkinson’s disease

Stige, K. E., Kverneng, S. U., Sharma, S., Skeie, G. O., Sheard, E. V., Søgnen, M., Geijerstam, S. A. A., Vetås, T., Wahlvåg, A. G., Berven, H., et al. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102603 · Cited by 13 · see citing works

The Therapeutic Benefits of Intravenously Administrated Nanoparticles in Stroke and Age-related Neurodegenerative Diseases

Farhoudi, M., Sadigh‐Eteghad, S., Mahmoudi, J., Farjami, A., Mahmoudian, M., & Salatin, S. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220608093639 · Cited by 13 · see citing works

Detection of Cortical Microbleeds in Postmortem Brains of Patients with Lewy Body Dementia: A 7.0-Tesla Magnetic Resonance Imaging Study with Neuropathological Correlates

Reuck, J. L. D., Auger, F., Durieux, N., Cordonnier, C., Deramecourt, V., Lebert, F., Leys, D., Pasquier, F., Maurage, C., & Bordet, R. (2015) · European Neurology · doi:10.1159/000441057 · Cited by 13 · see citing works

Treatment with a herbal formula B401 enhances neuroprotection and angiogenesis in the R6/2 mouse model of Huntington’s disease

Wu, C., Wang, S.-E., Lin, C.-L., Hsu, C.-H., Sheu, S.-J., & Chien, C. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s78015 · Cited by 12 · see citing works

Blood–Brain Barrier Breakdown in Stress and Neurodegeneration: Biochemical Mechanisms and New Models for Translational Research

Salmina, A. B., Komleva, Y. K., Malinovskaya, N. A., Morgun, A. V., Тепляшина, Е. А., Lopatina, O. L., Gorina, Y. V., Kharitonova, E. V., Хилажева, Е. Д., & Shuvaev, А. N. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921060122 · Cited by 12 · see citing works

Involvement of an Aberrant Vascular System in Neurodevelopmental, Neuropsychiatric, and Neuro-Degenerative Diseases

Ishihara, K., Takata, K., & Mizutani, K. (2023) · Life · doi:10.3390/life13010221 · Cited by 10 · see citing works

Differences in Retinal and Choroidal Microvasculature and Structure in Dementia With Lewy Bodies Compared With Normal Cognition

Joseph, S., Robbins, C. B., Allen, A., Haystead, A., Hemesath, A., Kundu, A., Ma, J. P., Johnson, K. G., Agrawal, R. V., Gunasan, V., et al. (2023) · Journal of VitreoRetinal Diseases · doi:10.1177/24741264231206607 · Cited by 9 · see citing works

Neuroretinal and microvascular retinal features in dementia with Lewy body assessed by optical coherence tomography angiography

Albanese, G. M., Gharbiya, M., Visioli, G., Panigutti, M., Margarella, A., Romano, E., Mastrogiuseppe, E., Sepe‐Monti, M., Bruno, G., & D’Antonio, F. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07683-6 · Cited by 9 · see citing works

Neuroinflammation in Movement Disorders

Saavedra-López, E., Casanova, P. V., Cribaro, G. P., & Barcia, C. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00038-6 · Cited by 8 · see citing works

Original article Prevalence of small cerebral bleeds in patients with progressive supranuclear palsy: a neuropathological study with 7.0-Tesla magnetic resonance imaging correlates

Reuck, J. D., Caparros-Lefebvre, D., Deramecourt, V., Defebvre, L., Auger, F., Durieux, N., Bordet, R., Pasquier, F., & Maurage, C. (2014) · Folia Neuropathologica · doi:10.5114/fn.2014.47843 · Cited by 7 · see citing works

Druggable targets for Parkinson’s disease: transcriptomics based Mendelian randomization study

Lyu, Q., Chen, R., Qiu, Z., Wang, C., & Liu, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-77401-x · Cited by 6 · see citing works

Role of Liver Growth Factor (LGF) in Parkinson’s Disease: Molecular Insights and Therapeutic Opportunities

Angelopoulou, E., Paudel, Y. N., & Piperi, C. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02326-9 · Cited by 6 · see citing works

A Water-soluble Form of Dihydroquercetin Reduces LPS-induced Astrogliosis, Vascular Remodeling, and mRNA VEGF-A Levels in the Substantia Nigra of Aged Rats

Alalykina Elena, S., Sergeyeva, T., Ananyan Michail, A., Анатольевич, Ч. И., & Sergeev Valeriy, G. (2024) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001092 · Cited by 5 · see citing works

Impaired neuronal activity as a potential factor contributing to the underdeveloped cerebrovasculature in a young Parkinson’s disease mouse model

Jeong, J.-Y., Lee, H. J., Kim, N., Li, Y., Rah, J., & Oh, W. (2023) · Scientific Reports · doi:10.1038/s41598-023-49900-w · Cited by 5 · see citing works

The topography of cortical microbleeds in frontotemporal lobar degeneration: a post-mortem 7.0-tesla magnetic resonance study

Reuck, J. D., Auger, F., Durieux, N., Deramecourt, V., Maurage, C., Lebert, F., Leys, D., Cordonnier, C., Pasquier, F., & Bordet, R. (2016) · Folia Neuropathologica · doi:10.5114/fn.2016.60364 · Cited by 5 · see citing works

Blood vessels and Parkinsonism

Barcia, C. (2004) · Frontiers in Bioscience · doi:10.2741/1145 · Cited by 41 · see citing works

Increased CSF biomarkers of angiogenesis in Parkinson disease

Janelidze, S., Lindqvist, D., Francardo, V., Hall, S., Zetterberg, H., Blennow, K., Adler, C. H., Beach, T. G., Serrano, G. E., van Westen, D., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002151 · Cited by 150 · see citing works

Microvascular Changes in Parkinson’s Disease- Focus on the Neurovascular Unit

Paul, G., & Elabi, O. F. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.853372 · Cited by 97 · see citing works

A neuroprotective role for angiogenin in models of Parkinson’s disease

Steidinger, T. U., Standaert, D. G., & Yacoubian, T. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07112.x · Cited by 76 · see citing works

Angiogenesis in Parkinson’s Disease

Madjidova, Y. N., Rasulova, K. A., & Fakhargalieva, S. (2016) · NATIONAL JOURNAL OF NEUROLOGY · doi:10.28942/nnj.v2i2(10).51